Skip to main content
Top
Published in: European Journal of Pediatrics 10/2017

01-10-2017 | Short Communication

Genital lichen sclerosus in childhood and adolescence—a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae

Authors: Ioannis Nerantzoulis, Themistoklis Grigoriadis, Lina Michala

Published in: European Journal of Pediatrics | Issue 10/2017

Login to get access

Abstract

Lichen sclerosus is a chronic skin disease, mainly localised at the introitus and perineum. When the condition remains untreated, gradual atrophy of skin structures leads to permanent scarring, making early diagnosis and treatment crucial. We reviewed all patients diagnosed with lichen sclerosus presenting to a tertiary referral centre for paediatric and adolescent gynaecology between January 2011 and December 2015 to assess disease presentation and response to treatment. We identified 15 cases, with a mean age at diagnosis of 8.8 years. Their main presenting symptoms were vulvar pruritus and vulvar soreness. Seven girls had already atrophic changes, and in four girls, this amounted to clitoral phimosis, labial resorption or labial adhesion formation. The median delay in diagnosis was 7 months. Thirteen patients received local treatment with potent corticosteroids, responding well to treatment. However, 4 girls relapsed within 2 to 36 months. Two adolescents required surgical treatment, one because of urinary retention and the second because of dyspareunia caused by clitoral entrapment.
Conclusions: There was a delay in diagnosis in most patients and this resulted in irreversible genital skin changes, which would have been preventable, had treatment been instituted promptly. The response to treatment with local corticosteroids was usually effective, leading to both symptom alleviation and prevention of disease progression. Atrophic changes and skin complications however were not reversed.
What is Known:
Lichen sclerosus affects women of all ages, including girls, particularly prior to adolescence.
Lichen sclerosus responds well to local corticosteroid treatment.
What is New:
In the majority of patients with lichen sclerosus there was a long delay between onset of symptoms and diagnosis.
Nearly half of the children diagnosed with lichen sclerosus had irreversible atrophic genital skin changes at the time of first presentation. These changes may have been prevented by a timely diagnosis and intervention.
Literature
1.
go back to reference Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS (2014) Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 27:111–116CrossRefPubMed Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS (2014) Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 27:111–116CrossRefPubMed
2.
go back to reference Bleeker MC, Visser PJ, Overbeek LI, van Beurden M, Berkhof J (2016) Lichen Sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomark Prev 25:1224–1230CrossRef Bleeker MC, Visser PJ, Overbeek LI, van Beurden M, Berkhof J (2016) Lichen Sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomark Prev 25:1224–1230CrossRef
3.
go back to reference Hengge UR, Krause W, Hofmann H, Stadler R, Gross G, Meurer M, Brinkmeier T, Frosch P, Moll I, Fritsch P, Muller K, Meykadeh N, Marini A, Ruzicka T, Gollnick H (2006) Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 155:1021–1028CrossRefPubMed Hengge UR, Krause W, Hofmann H, Stadler R, Gross G, Meurer M, Brinkmeier T, Frosch P, Moll I, Fritsch P, Muller K, Meykadeh N, Marini A, Ruzicka T, Gollnick H (2006) Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 155:1021–1028CrossRefPubMed
4.
go back to reference Kirtschig G, Becker K, Gunthert A, Jasaitiene D, Cooper S, Chi CC, Kreuter A, Rall KK, Aberer W, Riechardt S, Casabona F, Powell J, Brackenbury F, Erdmann R, Lazzeri M, Barbagli G, Wojnarowska F (2015) Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 29:e1–43CrossRefPubMed Kirtschig G, Becker K, Gunthert A, Jasaitiene D, Cooper S, Chi CC, Kreuter A, Rall KK, Aberer W, Riechardt S, Casabona F, Powell J, Brackenbury F, Erdmann R, Lazzeri M, Barbagli G, Wojnarowska F (2015) Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 29:e1–43CrossRefPubMed
5.
go back to reference Li Y, Xiao Y, Wang H, Li H, Luo X (2013) Low-concentration topical tacrolimus for the treatment of anogenital lichen sclerosus in childhood: maintenance treatment to reduce recurrence 3. J Pediatr Adolesc Gynecol 26:239–242CrossRefPubMed Li Y, Xiao Y, Wang H, Li H, Luo X (2013) Low-concentration topical tacrolimus for the treatment of anogenital lichen sclerosus in childhood: maintenance treatment to reduce recurrence 3. J Pediatr Adolesc Gynecol 26:239–242CrossRefPubMed
6.
go back to reference Maronn ML, Esterly NB (2005) Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 115:e230–e232CrossRefPubMed Maronn ML, Esterly NB (2005) Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 115:e230–e232CrossRefPubMed
7.
go back to reference Ormerod AD (2005) Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 153:701–705CrossRefPubMed Ormerod AD (2005) Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 153:701–705CrossRefPubMed
9.
go back to reference Smith SD, Fischer G (2009) Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol 26:725–729CrossRefPubMed Smith SD, Fischer G (2009) Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol 26:725–729CrossRefPubMed
10.
go back to reference Smith YR, Quint EH (2001) Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 98:588–591PubMed Smith YR, Quint EH (2001) Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 98:588–591PubMed
11.
go back to reference Tong LX, Sun GS, Teng JM (2015) Pediatric lichen sclerosus: a review of the epidemiology and treatment options. Pediatr Dermatol 32:593–599CrossRefPubMed Tong LX, Sun GS, Teng JM (2015) Pediatric lichen sclerosus: a review of the epidemiology and treatment options. Pediatr Dermatol 32:593–599CrossRefPubMed
Metadata
Title
Genital lichen sclerosus in childhood and adolescence—a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae
Authors
Ioannis Nerantzoulis
Themistoklis Grigoriadis
Lina Michala
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 10/2017
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-3004-y

Other articles of this Issue 10/2017

European Journal of Pediatrics 10/2017 Go to the issue